- Global Pharma News & Resources

Life Science Logistics Announces New Indiana Facility, Entry Into Raleigh-Durham to Meet Coast-to-Coast Demand

Company surpasses 4 million sq. ft. U.S. footprint, adds 100-200 new jobs with latest controlled-temperature, cold storage facility additions

DALLAS--(BUSINESS WIRE)--After years of unrelenting demand for FDA-regulated, controlled-temperature storage and distribution of pharmaceuticals and medical devices, Life Science Logistics (LSL), a leading, national provider of healthcare supply chain solutions, today announced the company will open another multi-client facility near Indianapolis in January 2022, creating 50-100 jobs and planting a larger flag for LSL in the U.S. distribution “hub” city.

The news of the 440,000 sq. ft. Clayton, Ind. facility – the third LSL multi-client, controlled-temperature/cold storage facility in the Indianapolis area – comes on the heels of LSL’s announcement in late Sept. 2021 that the company has acquired a 132,000 sq. ft. facility in Raleigh-Durham’s Research Triangle Park (to open in early 2022) to respond to client demand in that market. Combined, these facilities will create between 100-200 new jobs.

“All of the hard work we’ve been doing for the past 15 years to perfect our operations, manage quality and listen closely to our clients’ needs has led us to this moment,” said CEO Richard Beeny. “We’ve watched the consolidation of 3rd-party logistics providers across our industry and are proud to be the last and leading independent standing in a sea of middle-market demand. Our clients are saying ‘please build it, we need more’ – and we want to be their ‘Easy’ button.”

The fast-growing company of more than 600 employees, which currently has 12 controlled-temperature (20-25 degrees Celsius) and cold chain (2-8 degrees Celsius) storage and distribution locations across nine states – from Dallas to New York to Seattle – aims to continue its coast-to-coast growth with the expansion in Indianapolis and entry into Raleigh-Durham, according to Beeny.

He points to the speed with which new FDA-approved pharmaceutical and medical devices are being brought to market, as well demand for storage and distribution services driven by COVID-19 and injectable drugs with “live” particulates requiring extreme freezes to preserve vaccine integrity, as the primary drivers of growth.

When combined with the existing 526,299 sq. ft. at the Brownsburg, Ind. facility and the 189,458 sq. ft. at the Whitestown, Ind. facility, the new, 440,000 sq. ft. Clayton facility brings LSL’s total combined Indianapolis footprint of mixed-use, FDA-regulated storage and distribution space to more than 1 million sq. ft. The remaining 3 million sq. ft. of space is spread across LSL’s other coast-to-coast facilities.

About Life Science Logistics

Founded in 2006, DFW-based Life Science Logistics (LSL) is a leading, national provider of end-to-end, high-quality, customizable healthcare supply chain solutions. For clients ranging from Fortune 500 companies to startups, LSL offers its pharmaceutical, medical device, and biotech clients the ability to outsource services ranging from distribution to kitting to back- and middle-office functions. FDA-registered and VAWD-accredited, LSL will soon operate from 14 locations totaling more than 4 million square feet of cGMP compliant space.


Melissa Flynn

Editor Details

  • Company:
    • Businesswire
Last Updated: 05-Oct-2021